General Information
Revision date
2020-12-18
Product name
EXTRALYSE
supplier name
LAFFORT FRANCE
Emergency telephone
Comment
Icons in SDS
Company Information
company name
LAFFORT FRANCE
e-mail address of the competent person responsible for the Safety Data Sheet
info@laffort.com, laffortitalia@laffort.com, laffortusa@laffort.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H334
Hazard statements
Code
Statements
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
CLP CLASSIFICATION
Respiratory sensitisation, Category 1 H334
Hazard statements
see section 16 : H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling according to Regulation (EC) No. 1272/2008 [CLP]Extra labelling to displayExtra classification(s) to display
Hazard pictograms
GHS08
Signal word
Danger
Hazardous Ingredients
Polygalacturonase enzyme; Beta-glucanase enzyme
Precautionary statements
P261 - Avoid breathing dust, fume, gas, mist, vapours, spray. P280 - Wear protective gloves, protective clothing/eye protection/face protection. P284 - In case of inadequate ventilation wear respiratory protection. P304+P340 - IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P342+P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.
Other hazards which do not result in classification
May cause sensitization by inhalation and skin contact. mild eye irritation. mild skin irritation.
